PeterMD Review 2026: Keep Each Weight-Loss Offer Separate
Affiliate and editorial disclosure: DrBaba.com may receive compensation if a reader uses the Official Site link. This independent educational review is not medical advice and does not claim that our team enrolled with PeterMD, received a prescription, used a medicine, or verified an outcome.
Medication-Reconciliation Checklist
| What PeterMD presents | Separate GLP1, GLP1 + B12, tirzepatide, B12 + MIC, phentermine, and bundle contexts—not one interchangeable program. |
|---|---|
| Clinical decision | A clinician may assess you and retains discretion to prescribe, decline, request more information, or recommend another path. |
| Before payment | Get the order-specific pharmacy, formulation, dose, safety, billing, cancellation, and fulfillment terms in writing. |
| Official Site | Review PeterMD’s current official presentation |
By DrBaba.com Health Research Team
When an online weight-management page shows several medication names and several prices, the safest starting point is separation. PeterMD’s captured pages describe online clinician-led weight-management offerings, but they do not turn every listing into the same medicine, the same dose, or the same care plan. A careful intake begins by matching each possible offer to your complete medication list and your clinician’s judgment.
PeterMD’s weight-loss page lists GLP1, B12 + MIC, tirzepatide, and phentermine as separate options. Its other captures describe a GLP1 + B12 program and a tirzepatide page. These labels are not permission to combine facts across pages. A price shown beside one offer, an availability statement on another page, or a marketing statement about a category should not be carried into a different option.
Start with roles, not checkout language
PeterMD describes 100% online care, unlimited provider access, U.S.-sourced medications, simple upfront pricing, free discreet delivery, and FDA-regulated care providers. Those are PeterMD seller statements. They do not establish the details of your order or replace an individualized assessment.
Keep the roles clear. PeterMD presents the online service. The clinician evaluates your history and decides whether prescribing is appropriate. A pharmacy, if one is involved in filling an approved order, has a separate dispensing role. The four captures do not name the dispensing pharmacy. They also do not provide your formulation, ingredient list, dose, concentration, or complete eligibility rules. For basic context on this care setting, see DrBaba’s guide to what telehealth is, how it works, and what it can cost.
Reconcile your medicines before discussing any offer
Medication reconciliation means making one complete, current list before the clinical conversation. Include prescriptions, nonprescription medicines, vitamins, herbs, supplements, allergy history, recent procedures, and the names of clinicians already involved in your care. Do not assume an online intake automatically captures everything important.
Bring that list to the prescriber and ask which exact option is under consideration. Ask how it fits with your present medicines and conditions, who will handle follow-up, and what information should be shared with your usual clinician. A remote visit can still require careful preparation; this overview of what happens during a telehealth visit explains why clear history and direct questions matter. The prescriber may decide that a different treatment, an in-person evaluation, or no prescription is the safer choice.
Read each offer as its own document
On the captured weight-loss landing page, PeterMD displays a Basic Weight Loss offer at $315.00 for 10–12 weeks of GLP1. The same page separately displays an Enhanced Weight Loss offer at $402.00 for 10–12 weeks of GLP1 and B12 + MIC. These are seller-presented bundle contexts. They are not interchangeable plan prices, and they do not describe the separate GLP1 + B12 levels or the tirzepatide page.
On the captured GLP1 + B12 page, PeterMD displays Level 1 at $149/month and $447 total for an estimated 10–12 week supply. It separately displays Level 2 at $139/month and $834 total for an estimated 8–12 week supply. That page also separately shows a recommended 3-month plan at $315.00, marked against a $358.00 regular price. Nearby price-match wording refers to TRT, so it should not be generalized to GLP1 + B12.
The captured tirzepatide page has its own seller-rendered contexts: “Get Started for $149,” “$249 per month • billed quarterly,” and $315.00 and $628.00 displays for a 60 mg plan. The capture does not provide enough terms to calculate a final cost or compare it with another page. Do not merge these displays, estimate a discount, or treat one number as the price of all PeterMD care.
Where marketing language must stop
PeterMD’s weight-loss capture uses “same active ingredient” language in marketing alongside compounded-product wording. That is a seller claim, not a fact this review can verify. It does not establish that a compounded PeterMD product is FDA approved, generic, branded, identical, bioequivalent, equivalent, interchangeable, substitutable, or made with the same active ingredient as an FDA-approved branded drug.
Likewise, the GLP1 + B12 and tirzepatide captures contain mixed FDA-approved language while describing compounded medication. That mixed copy does not establish FDA approval for a compounded product or equivalence with an approved brand. Keep the exact proposed product and its written documentation in front of the clinician and pharmacist. Marketing, testimonials, ratings, affordability comparisons, and outcome language presented by PeterMD are not independent proof or a promise of an individual result.
Missing terms are a reason to pause
The captures do not provide a named dispensing pharmacy; an applicant-specific formulation, ingredients, dose, or concentration; complete eligibility criteria; or full safety, contraindication, interaction, and storage terms. They also do not provide complete cancellation, refund, billing, or shipment-remedy terms. These are practical gaps, not minor fine print.
Before paying, request in writing: the exact offer under review, the total and billing schedule that applies to it, the dispensing pharmacy, the formulation and concentration if prescribed, medication-specific instructions, storage and delivery guidance, who answers a delayed-shipment question, and the cancellation and refund rules. Ask whether the GLP1 + B12 availability statement excluding AL, ID, AK, and HI applies to your exact request; do not assume it applies to every offer. PeterMD’s tirzepatide capture separately says availability excludes AL and ID, which is another reason not to blend the pages.
Who should not use this as a shortcut
This is not for someone seeking a guaranteed prescription, a fixed dose, a designed to support result, a branded or FDA-approved product by assumption, or a final price without written terms. It is also not a substitute for coordinated care when your medication list is incomplete, you have complex health needs, or your regular care team needs to be involved.
Questions about side effects or concerning symptoms should go to the treating clinician or another appropriate local medical professional. DrBaba’s explanation of GLP-1 side effects: normal versus serious may help you prepare questions, but it cannot direct your individual treatment. Severe or urgent symptoms require 911 or local emergency services; do not wait for an online message, a routine follow-up, or a shipment update.
Bottom line
PeterMD’s captures present several separate weight-loss offer contexts, not a single standardized product. The responsible next step is a complete medication reconciliation, a clinician-led decision, and written confirmation of the exact order’s pharmacy, formulation, safety information, cost, billing, delivery, and cancellation terms. Keep each offer in its own lane until those details are documented.
Medical disclaimer: This article provides general education only. A licensed clinician who evaluates your health history is the appropriate person to diagnose, prescribe, and advise on treatment.